510(k) Report

510(k) · Cleared

Cleared

STA R Max 3, STA Compact Max 3

K212183510(k) TraditionalCleared Jun 7, 2023694-day reviewClass II21 CFR 864.5425

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagnostica Stago S.A.S · JPA System, Multipurpose For In Vitro Coagulation Studies

Cleared on Jun 7, 2023 as substantially equivalent to K151867 (Diagnostica Stago S.A.S, 2015) and 1 other predicate after a 694-day review. Its family tree reaches back 5 generations to 1995.

Decided
Jun 7, 2023
Review
694 days
Class
Class II
Product code
JPA
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K942117 (1995). 8 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK942117 Sta Automated Multi-Parametric AnalyzerAmerican Bioproducts Co. · 1995
  2. 4 generations backK983460 Star Automated Multi-Parametric AnalyzerAmerican Bioproducts Co. · 1998 · Recalled
  3. 3 generations backK082675 Sta-R Evolution Automated Multi-Parametric AnalyzerDiagnostica Stago, Inc. · 2008
  4. 2 generations backK093001 Sta-R Evolution Expert Series Hemostasis System Automated…Diagnostica Stago, Incorporated · 2009
  5. 1 generation backK151867 Sta R MaxDiagnostica Stago S.A.S · 2015 · Recalled
  6. This deviceK212183 STA R Max 3, STA Compact Max 3Diagnostica Stago S.A.S · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K942117Sta Automated Multi-Parametric AnalyzerAmerican Bioproducts Co.1995—
−4K983460Star Automated Multi-Parametric AnalyzerAmerican Bioproducts Co.19981
−3K082675Sta-R Evolution Automated Multi-Parametric AnalyzerDiagnostica Stago, Inc.2008—
−2K093001Sta-R Evolution Expert Series Hemostasis System Automated Multi-Parametric…Diagnostica Stago, Incorporated2009—
−1K151867Sta R MaxDiagnostica Stago S.A.S20151
0 (this device)K212183STA R Max 3, STA Compact Max 3Diagnostica Stago S.A.S2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
200910
201310
FIG. 1 — Lineage of K212183, 1995–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JPA device

  1. #1 K243858 TEG 6s Hemostasis System Citrated: K, KH, RT…score 12.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K151867Sta R Max
Summary page 4
…h aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy. 3. Predicate Device Device Name: STA R Max® (K151867) / STA Compact Max® (K130090) Common Name: Automated Coagulation Analyzer Classification Name:…
Diagnostica Stago S.A.S20151
*K130090Sta Compact Max
Summary page 4
…gulation abnormalities or in monitoring anticoagulant therapy. 3. Predicate Device Device Name: STA R Max® (K151867) / STA Compact Max® (K130090) Common Name: Automated Coagulation Analyzer Classification Name: System, Multipu…
Diagnostica Stago, Incorporated20131

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 28 years and passes through 4 companies; a new generation was cleared every 5.6 years on median.
  • 5 of the 8 ancestors have a recall of any class.

How does its category compare?

All JPA devices

JPA System, Multipurpose For In Vitro Coagulation Studies: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · JPA

3in 2025

2007: 12008: 22009: 62010: 12011: 12013: 12015: 22016: 62017: 42018: 12019: 32021: 12022: 12023: 32024: 12025: 32026 (partial year): 1
2007high 6 (2009) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JPA

30in 2025

2009: 91 days median2016: 114 days median2017: 117 days median2019: 175 days median2023: 506 days median2025: 30 days median
2007high 506 (2023) · low 30 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JPA

1in 2020

2007: 12010: 62011: 42012: 12016: 32020: 12026 (partial year): 1
2007high 6 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JPA

11in 2025

2007: 1,7442008: 9182009: 1,3632010: 7272011: 1612012: 522013: 432014: 482015: 452016: 62017: 152018: 392019: 272020: 182021: 72022: 92023: 112024: 82025: 11
2007high 1,744 (2007) · low 6 (2016)2025

MAUDE reports naming product code JPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—11,744
20082—0918
200969101,363
20101—6727
20111—4161
20120—152
20131—043
20140—048
20152—045
2016611436
20174117015
20181—039
20193175027
20200—118
20211—07
20221—09
20233506011
20241—08
2025330011
20261—1—

What is it indicated for?

The STA R Max 3® and STA Compact Max 3® are fully automatic clinical analyzers designed to be used by professional laboratory personnel and to perform tests on human venous plasmas (in 3.2% trisodium citrate tubes) the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K212183: STA R Max 3, STA Compact Max 3.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K212183

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026